SEC Form 4 · accession 0001493152-16-007166
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Lange Elliot Jr.
Director · 10% Owner
Period of report
Sep 2, 2015
Accepted (ET)
Feb 4, 2016 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 2, 2015 | A | 17,951,079 | — | A | 17,951,079 | D | |
| Common stock | Sep 2, 2015 | S | 1,025,000 | $0.001 | D | 16,926,079 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Received in exchange for all of the reporting person's shares of OncBioMune, Inc. ("ONC") common stock in connection with the exchange pursuant to that certain exchange agreement dated as of June 22, 2015, as amended, among the registrant, ONC and the ONC shareholders.